𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adjuvant CMF (cyclophosphamide, methotrexate, fluorouracil) in breast cancer. Is it cost-effective?

✍ Scribed by J. Norum


Book ID
117667858
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
135 KB
Volume
35
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The effect of postoperative and primary
✍ Jedd F. Levine; C. Norman Coleman; Richard S. Cox; Gordon R. Ray; William M. Rog πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 457 KB πŸ‘ 2 views

The dose of adjuvant chemotherapy for breast cancer may be an important factor in the success of the treatment program. In a retrospective analysis, the authors determined whether patients who were irradiated either postoperatively (N = 29) or as part of primary treatment (N = 13) received a lower d